title: Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden.
authors.affiliation: IMS Health, London, UK.
authors.forename: V
authors.initials: V
authors.lastname: Barzey
authors.affiliation: IMS Health, London, UK.
authors.forename: Y
authors.initials: Y
authors.lastname: Asukai
authors.affiliation: Bristol-Myers Squibb, Rueil Malmasion, France.
authors.forename: B
authors.initials: B
authors.lastname: Gueron
authors.affiliation: Bristol-Myers Squibb, Bromma, Sweden.
authors.forename: C
authors.initials: C
authors.lastname: Holmberg
authors.affiliation: Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kotapati